San Francisco, CA: Individuals who regularly smoke cigarettes and
marijuana experience a greater likelihood of developing symptoms of
chronic obstructive pulmonary disease (COPD) than do individuals who
smoke cigarettes only, according to clinical data presented this week
at the 2007 International Conference of the American Thoracic Society.
Investigators at St. Paul's Hospital in Vancouver, British
Columbia, reported that the combined use of tobacco and marijuana was
associated with an increased risk of COPD among individuals age 40 and
older. Researchers found that cigarette-only smokers were
two-and-a-half times more likely than nonsmokers to develop COPD, while
those subjects who reported smoking both substances were
three-and-a-half times more likely.
Investigators did not report whether individuals who consumed
only cannabis were at a higher risk for developing COPD compared to
nonusers.
A recent meta-analysis published in the Archives of Internal
Medicine reports that although chronic cannabis smoking is associated
with an elevated risk of respiratory complications – including an
increase in cough, sputum production, and wheezing – it is not
associated with a decline in pulmonary function.
Authors of the Canadian study did not suggest whether vaporizing
cannabis would reduce its adverse interaction with tobacco smoke.
Last month, investigators at San Francisco General Hospital
reported that use of the Volcano vaporizing device significantly
reduces cannabis consumers' intake of gaseous combustion toxins,
including carbon monoxide. A separate study conducted by investigators
at the University of Albany reports that marijuana consumers who
vaporize pot are less likely to suffer from respiratory symptoms than
are those who do not vaporize, after controlling for subjects' age,
sex, and cigarette use.
Vaporization heats cannabis to a temperature where active
cannabinoid vapors form (typically around 180-190 degrees Celsius), but
below the point of combustion where noxious smoke and associated toxins
(i.e., carcinogenic hydrocarbons) are produced (above 230 degrees
Celsius).
For more information, please contact Paul Armentano, NORML
Senior Policy Analyst, at:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
. Abstracts of the study,
"The impact of cigarette and marijuana smoking in a chronic obstructive
lung disease study in Vancouver, Canada," are available online at:
http://www.thoracic.org/ . Additional information on the impact of
cannabis smoking on the lungs is available in the NORML white paper,
"Cannabis Smoke and Cancer:
Assessing the Risk," available online at: http://www.norml.org/index.cfm?Group_ID=6891 .
|